A multicenter study led by Vanderbilt University Medical Center and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.

Legendary civil rights activist Diane Nash visited the emergency department at Vanderbilt University Medical Center on April 20 to acknowledge the naming of a physician team in her honor. 

Julie Bastarache, MD, Assistant Vice President for Clinical & Translational Scientist Development at Vanderbilt University Medical Center, has been elected vice president of the American Society for Clinical Investigation (ASCI) for 2024-2025.

Vanderbilt researchers have identified cancer cell-specific genetic alterations that reprogram the immune “landscape,” thereby driving tumor growth, and discovered a potential new drug target for stopping it.

In a national retrospective study led by researchers at Vanderbilt University School of Medicine, diltiazem, when given in combination with the anticoagulant drugs apixaban (Eliquis) or rivaroxaban (Xarelto), significantly increased the risk of serious bleeding compared to metoprolol.

Coronary artery disease and major depression may be genetically linked via inflammatory pathways to an increased risk for cardiomyopathy, a degenerative heart muscle disease, researchers at Vanderbilt University Medical Center and Massachusetts General Hospital have found.